Search hospitals
>
Mississippi
>
Jackson
University Of Mississippi Medical Center
Claim this profile
Jackson, Mississippi 39216
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Brain Tumor
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
1030 reported clinical trials
45 medical researchers
Summary
University Of Mississippi Medical Center is a medical facility located in Jackson, Mississippi. This center is recognized for care of Cancer, Leukemia, Brain Tumor, Lung Cancer, Ovarian Cancer and other specialties. University Of Mississippi Medical Center is involved with conducting 1,030 clinical trials across 1,197 conditions. There are 45 research doctors associated with this hospital, such as Anderson (Andy) B. Collier, Betty L. Herrington, John C. Henegan, and Dennis P. Morgan.
Area of expertise
Cancer
University Of Mississippi Medical Center has run 77 trials for Cancer. Some of their research focus areas include:
Leukemia
University Of Mississippi Medical Center has run 67 trials for Leukemia. Some of their research focus areas include:
Top PIs
Anderson (Andy) B. Collier
University of Mississippi Medical Center
8 years of reported clinical research
Betty L. Herrington
University of Mississippi Medical Center
8 years of reported clinical research
John C. Henegan
University of Mississippi Medical Center
4 years of reported clinical research
Dennis P. Morgan
University of Mississippi Medical Center
6 years of reported clinical research
Clinical Trials running at University Of Mississippi Medical Center
Bladder Cancer
Prostate Cancer
Bladder Carcinoma
Kidney Cancer
Testicular cancer
Breast cancer
Lung Cancer
Leukemia
Neuroblastoma
Acute Lymphoblastic Leukemia
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Disitamab Vedotin + Pembrolizumab vs Chemotherapy
for Bladder Cancer
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting
2 awards
Phase 3
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University Of Mississippi Medical Center?
University Of Mississippi Medical Center is a medical facility located in Jackson, Mississippi. This center is recognized for care of Cancer, Leukemia, Brain Tumor, Lung Cancer, Ovarian Cancer and other specialties. University Of Mississippi Medical Center is involved with conducting 1,030 clinical trials across 1,197 conditions. There are 45 research doctors associated with this hospital, such as Anderson (Andy) B. Collier, Betty L. Herrington, John C. Henegan, and Dennis P. Morgan.
Where is University Of Mississippi Medical Center located?
The University of Mississippi Medical Center is located at 2500 N State St, Jackson, MS 39216. Access is available via the stoplight at University Drive on North State Street or by taking I-55 to the Woodrow Wilson exit (98A), following signs to the new Children's Parking Garage C.
Who should I call to ask about financial aid or insurance network?
**University Of Mississippi Medical Center (UMMC) Financial and Billing Information:** - For financial assistance, contact Patient Financial Services at 410-821-4140 or 877-632-4909 (toll-free) to check eligibility for the UMMC Financial Assistance Program or other assistance programs. - For insurance inquiries, reach out to the Mississippi Insurance Department via their website. - For billing questions or concerns, contact UMMC's Central Billing Office at (601) 496-9303 or (844) 838-4871.
What insurance does University Of Mississippi Medical Center accept?
The University of Mississippi Medical Center (UMMC) accepts various insurance plans, including those from UnitedHealthcare, Blue Cross Blue Shield of Mississippi, and Humana. UMMC offers a student insurance plan through UnitedHealthcare for students with at least 6 credit hours and their dependents; international students are required to have health insurance. Additionally, UMMC has in-network agreements with Blue Cross Blue Shield for all commercial health plans and with Humana for Medicare Advantage HMO and PPO plan members.
What awards or recognition has University Of Mississippi Medical Center received?
The University of Pennsylvania has been awarded the 2022 update to the research and development section.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.